Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Magnesium in headache.

Yablon LA, Mauskop A.

In: Vink R, Nechifor M, editors. Magnesium in the Central Nervous System [Internet]. Adelaide (AU): University of Adelaide Press; 2011.

2.

Stem Cells in the Treatment of Refractory Chronic Migraines.

Mauskop A, Rothaus KO.

Case Rep Neurol. 2017 Jun 14;9(2):149-155. doi: 10.1159/000477393. eCollection 2017 May-Aug.

3.

Nutraceuticals in Acute and Prophylactic Treatment of Migraine.

Daniel O, Mauskop A.

Curr Treat Options Neurol. 2016 Apr;18(4):14. doi: 10.1007/s11940-016-0398-1.

PMID:
26923604
4.

Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study.

Goadsby PJ, Grosberg BM, Mauskop A, Cady R, Simmons KA.

Cephalalgia. 2014 Oct;34(12):986-93. doi: 10.1177/0333102414524494. Epub 2014 Mar 7.

PMID:
24607501
5.

Vagus nerve stimulation for refractory cluster headaches.

Mauskop A.

Headache. 2014 Jan;54(1):170. doi: 10.1111/head.12244. No abstract available.

PMID:
24400761
7.

Complementary and alternative approaches to the treatment of tension-type headache.

Sun-Edelstein C, Mauskop A.

Curr Pain Headache Rep. 2012 Dec;16(6):539-44. doi: 10.1007/s11916-012-0295-6. Review.

PMID:
22968473
8.

Nonmedication, alternative, and complementary treatments for migraine.

Mauskop A.

Continuum (Minneap Minn). 2012 Aug;18(4):796-806. doi: 10.1212/01.CON.0000418643.24408.40. Review.

PMID:
22868542
9.

Why all migraine patients should be treated with magnesium.

Mauskop A, Varughese J.

J Neural Transm (Vienna). 2012 May;119(5):575-9. doi: 10.1007/s00702-012-0790-2. Epub 2012 Mar 18. Review.

PMID:
22426836
10.

Predictors of statin adherence.

Mauskop A, Borden WB.

Curr Cardiol Rep. 2011 Dec;13(6):553-8. doi: 10.1007/s11886-011-0221-2. Review.

PMID:
21947789
11.

Alternative headache treatments: nutraceuticals, behavioral and physical treatments.

Sun-Edelstein C, Mauskop A.

Headache. 2011 Mar;51(3):469-483. doi: 10.1111/j.1526-4610.2011.01846.x. Review.

PMID:
21352222
12.

Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Mauskop A.

Neurology. 2010 Oct 12;75(15):1397; author reply 1398-9. doi: 10.1212/WNL.0b013e3181f003be. No abstract available.

PMID:
20938035
13.

Botulinum neurotoxin in the treatment of headache disorders.

Mauskop A.

Handb Clin Neurol. 2010;97:217-32. doi: 10.1016/S0072-9752(10)97017-6.

PMID:
20816423
14.

Foods and supplements in the management of migraine headaches.

Sun-Edelstein C, Mauskop A.

Clin J Pain. 2009 Jun;25(5):446-52. doi: 10.1097/AJP.0b013e31819a6f65. Review.

PMID:
19454881
15.

Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the american academy of neurology.

Mauskop A, Mathew N.

Neurology. 2009 Apr 14;72(15):1367; author reply 1367-8. doi: 10.1212/WNL.0b013e3181a53375. No abstract available. Erratum in: Neurology. 2009 Aug 18;73(7):573.

PMID:
19365063
16.

Role of magnesium in the pathogenesis and treatment of migraine.

Sun-Edelstein C, Mauskop A.

Expert Rev Neurother. 2009 Mar;9(3):369-79. doi: 10.1586/14737175.9.3.369. Review.

PMID:
19271946
17.

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel.

J Pain. 2009 Feb;10(2):113-30. doi: 10.1016/j.jpain.2008.10.008.

18.

Complementary and alternative approaches to the treatment of tension-type headache.

Sun-Edelstein C, Mauskop A.

Curr Pain Headache Rep. 2008 Dec;12(6):447-50. Review.

PMID:
18973739
19.

Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.

Martin V, Cady R, Mauskop A, Seidman LS, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.

Headache. 2008 Feb;48(2):226-35. Epub 2007 Nov 13.

PMID:
18005144
20.

Symptoms of cutaneous sensitivity pre-treatment and post-treatment: results from the rizatriptan TAME studies.

Cady R, Martin V, Mauskop A, Rodgers A, Hustad C, Ramsey K, Skobieranda F.

Cephalalgia. 2007 Sep;27(9):1055-60. Epub 2007 Aug 6.

PMID:
17681023
21.

Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes.

Smith T, Blumenthal H, Diamond M, Mauskop A, Ames M, McDonald S, Lener S, Burch S.

Headache. 2007 May;47(5):683-92.

PMID:
17501849
22.

Botulinum toxin in headache treatment: the end of the road?

Mauskop A.

Cephalalgia. 2007 May;27(5):468. No abstract available.

PMID:
17448184
23.

Long-term migraine prevention with topiramate: open-label extension of pivotal trials.

Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.

Headache. 2006 Jul-Aug;46(7):1151-60.

PMID:
16866719
24.

The use of botulinum toxin in the treatment of headaches.

Mauskop A.

Pain Physician. 2004 Jul;7(3):377-87.

25.

Efficacy of Rizatriptan 10 mg administered early in a migraine attack.

Cady R, Martin V, Mauskop A, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.

Headache. 2006 Jun;46(6):914-24.

PMID:
16732837
26.

Treatment of headaches with botulinum toxin.

Samton J, Mauskop A.

Expert Rev Neurother. 2006 Mar;6(3):313-22. Review.

PMID:
16533136
27.
28.

Development of a brief assessment scale for caregivers of the medically ill.

Glajchen M, Kornblith A, Homel P, Fraidin L, Mauskop A, Portenoy RK.

J Pain Symptom Manage. 2005 Mar;29(3):245-54.

PMID:
15781175
29.
30.

Petasites hybridus root (butterbur) is an effective preventive treatment for migraine.

Lipton RB, Göbel H, Einhäupl KM, Wilks K, Mauskop A.

Neurology. 2004 Dec 28;63(12):2240-4.

PMID:
15623680
31.

Re: Hord ED et al. The effect of vagus nerve stimulation on migraines. J Pain. 2003 Nov;4(9):530-4.

Mauskop A.

J Pain. 2004 Mar;5(2):139; author reply 140. No abstract available.

PMID:
15042523
32.

Simplified butalbital withdrawal protocol.

Mauskop A.

Headache. 2004 Mar;44(3):290-1. No abstract available.

PMID:
15012672
33.

The use of botulinum toxin in the treatment of headaches.

Mauskop A.

Curr Pain Headache Rep. 2002 Aug;6(4):320-3. Review.

PMID:
12095468
34.

Clinical features of withdrawal headache following overuse of triptans and other headache drugs.

Mauskop A.

Neurology. 2002 May 14;58(9):1443; author reply 1443-4. No abstract available.

PMID:
12011309
35.
36.

Alternative therapies in headache. Is there a role?

Mauskop A.

Med Clin North Am. 2001 Jul;85(4):1077-84. Review.

PMID:
11480259
37.

Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache.

Mauskop A, Farkkila M, Hering-Hanit R, Rapoport A, Warner J.

Curr Med Res Opin. 1999;15(4):282-9.

PMID:
10640260
38.

Zolmitriptan provides consistent migraine relief when used in the long-term.

Tuchman M, Edvinsson L, Geraud G, Korczyn A, Mauskop A, Pfaffenrath V.

Curr Med Res Opin. 1999;15(4):272-81.

PMID:
10640259
39.

Evidence linking magnesium deficiency to migraines.

Mauskop A.

Cephalalgia. 1999 Nov;19(9):766-7. Review. No abstract available.

PMID:
10595282
40.

Role of magnesium in the pathogenesis and treatment of migraines.

Mauskop A, Altura BM.

Clin Neurosci. 1998;5(1):24-7. Review.

PMID:
9523054
41.

Intravenous magnesium sulfate rapidly alleviates headaches of various types.

Mauskop A, Altura BT, Cracco RQ, Altura BM.

Headache. 1996 Mar;36(3):154-60.

PMID:
8984087
42.

Intravenous magnesium sulphate relieves migraine attacks in patients with low serum ionized magnesium levels: a pilot study.

Mauskop A, Altura BT, Cracco RQ, Altura BM.

Clin Sci (Lond). 1995 Dec;89(6):633-6.

PMID:
8549082
43.

Intravenous magnesium sulfate relieves cluster headaches in patients with low serum ionized magnesium levels.

Mauskop A, Altura BT, Cracco RQ, Altura BM.

Headache. 1995 Nov-Dec;35(10):597-600.

PMID:
8550360
44.

Chronic daily headache--one disease or two? Diagnostic role of serum ionized magnesium.

Mauskop A, Altura BT, Cracco RQ, Altura BM.

Cephalalgia. 1994 Feb;14(1):24-8.

PMID:
8200019
45.

Clinical studies with the NOVA ISE for IMg2+.

Altura BT, Burack JL, Cracco RQ, Galland L, Handwerker SM, Markell MS, Mauskop A, Memon ZS, Resnick LM, Zisbrod Z, et al.

Scand J Clin Lab Invest Suppl. 1994;217:53-67. Review.

PMID:
7939386
46.

Trigeminal neuralgia (tic douloureux).

Mauskop A.

J Pain Symptom Manage. 1993 Apr;8(3):148-54.

PMID:
8326165
47.
48.

Headaches and children: a reply to "An urban primary school health program".

Mauskop A.

N Y State J Med. 1992 Jan;92(1):24. No abstract available.

PMID:
1574229
49.

Continuous subcutaneous infusions of opiates in cancer patients with pain.

Coyle N, Mauskop A, Maggard J, Foley KM.

Oncol Nurs Forum. 1986 Jul-Aug;13(4):53-7. No abstract available.

PMID:
2873557
50.

Cerebral infarction and subdural hematoma. Advantage of nuclear magnetic resonance imaging in cerebral ischemia.

Mauskop A, Wolintz AH, Valderrama R.

J Clin Neuroophthalmol. 1984 Dec;4(4):251-3.

PMID:
6240499

Supplemental Content

Loading ...
Support Center